IP Library Granted Patent US 8,016,774
Granted Patent B2
US 8,016,774 · App. 11/317,912 · Granted Sep 13, 2011

Tissue penetration device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,016,774
App. No.
11/317,912
Granted
Sep 13, 2011
Kind
B2
Abstract

An agent injection device is provided that is capable of injecting an agent to a known predetermined tissue depth. An injection member has an elongate injection shaft with an outlet port configured to dispense an agent at a controllable time. A controllable driver is coupled to the elongate injection shaft and is configured to drive the injection member into target tissue. A velocity control system is in communication with the controllable driver and is configured to control the velocity of the elongate injection shaft.

Claims (12)

1. An agent injection device capable of injecting an agent to a known tissue depth, comprising:

(a) an injection member having an elongate injection shaft with an outlet port configured to dispense an agent at a controllable time;

(b) a controllable electronic driver coupled to the elongate injection shaft and configured to drive the injection member into target tissue within a limit on injection stroke velocity of the injection member;

(c) a position sensor coupled to the controllable electronic driver, the position sensor configured to detect penetration depth as well as penetration and withdrawal velocities of the injection member;

(d) velocity control system including a feedback loop coupled to the position sensor and a processor in communication with the controllable electronic driver configured to control the injection member's penetration depth and penetration and withdrawal velocities to compensate for variations in skin thickness; and

(e) wherein the controllable electronic driver is configured to drive the elongate injection shaft at the injection stroke velocity of up to about 10 m/s.

2. The device of claim 1 , wherein the elongate injection shaft is configured to penetrate substantially perpendicular to target tissue.

3. The device of claim 1 , further comprising a housing with an elongate injection shaft port for the elongate injection shaft to exit and a sensor disposed adjacent the elongate injection shaft port that automatically activates an injection cycle upon sensing target tissue adjacent to the elongate injection shaft port.

4. The device of claim 1 , wherein the velocity control system is configured to control the depth of injection to an accuracy of better than about 200 microns.

5. The device of claim 4 , wherein the velocity control system is configured to control the depth of injection to an accuracy of better than about 40 microns.

6. The device of claim 1 , wherein the elongate injection shaft comprises a hypodermic needle.

7. The device of claim 1 , wherein the injection member comprises an agent reservoir with a main chamber in fluid communication with the outlet port of the elongate injection shaft.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2012
From: PELIKAN TECHNOLOGIES, INC.
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 028229/0524 →
RELEASE OF SECURITY INTEREST Recorded Mar 2, 2010
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 024016/0492 →
SECURITY AGREEMENT Recorded Dec 18, 2008
From: PELIKAN TECHNOLOGIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021998/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2006
From: FREEMAN, DOMINIQUE; BOECKER, DIRK; ALDEN, DON; BRIGGS, BARRY DEAN; LEONARD, JON HEWITT; FREEMAN, RAY; GOGUE, GEORGE
To: PELIKAN TECHNOLOGIES, INC.
Reel/Frame 017891/0289 →